WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.01 Cr | ₹-15 Cr | ₹-44 Cr | ₹130 Cr | ₹0.78 Cr |
What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1.01 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹-44 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹0.78 Cr |
How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.01 Cr | Positive | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹-44 Cr | Negative | |
| Mar2022 | ₹130 Cr | 16,663.92 | |
| Mar2021 | ₹0.78 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,613.8 Cr | 0.4% | -11.3% | -16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹453,750.0 Cr | 0.6% | 13.6% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,117.0 Cr | 1.5% | 9.1% | 9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,314.0 Cr | 1.5% | 8.2% | 35.7% | Stock Analytics | |
| CIPLA | ₹113,225.0 Cr | -2.1% | 13.7% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,037.0 Cr | -1.4% | 8% | 7.4% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 0.4% |
-11.3% |
-16.6% |
| SENSEX | -0.3% |
-4.3% |
-8.9% |
You may also like the below Video Courses